233 related articles for article (PubMed ID: 28559023)
1. The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement.
Tang LL; Tang XR; Li WF; Chen L; Tian L; Lin AH; Sun Y; Ma J
Oral Oncol; 2017 Jun; 69():68-73. PubMed ID: 28559023
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.
Zeng L; Sun XM; Chen CY; Han F; Huang Y; Xiao WW; Liu S; Tian YM; Deng XW; Lu TX
Head Neck; 2014 May; 36(5):687-93. PubMed ID: 23606573
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation.
Ou X; Shen C; Kong L; Wang X; Ding J; Gao Y; Xu T; Hu C
Oral Oncol; 2012 Oct; 48(10):1045-1050. PubMed ID: 22633108
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.
Chen M; Tang LL; Sun Y; Mao YP; Li WF; Guo R; Liu LZ; Li L; Lin AH; Ma J
Head Neck; 2014 Apr; 36(4):468-73. PubMed ID: 23780916
[TBL] [Abstract][Full Text] [Related]
5. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
[TBL] [Abstract][Full Text] [Related]
6. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
Li WF; Sun Y; Mao YP; Chen L; Chen YY; Chen M; Liu LZ; Lin AH; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):249-56. PubMed ID: 23200171
[TBL] [Abstract][Full Text] [Related]
7. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis.
Zhang F; Cheng YK; Li WF; Guo R; Chen L; Sun Y; Mao YP; Zhou GQ; Liu X; Liu LZ; Lin AH; Tang LL; Ma J
BMC Cancer; 2015 Oct; 15():709. PubMed ID: 26472233
[TBL] [Abstract][Full Text] [Related]
9. Parotid area lymph node metastases from preliminarily diagnosed patients with nasopharyngeal carcinoma: report on tumor characteristics and oncologic outcomes.
Xu Y; Zhang M; Xiao Y; Zong J; Qiu S; Bai P; Dai Y; Zhou L; Chen X; Zheng W; Chen Y; Lin S; Pan J
Oncotarget; 2016 Apr; 7(15):19654-65. PubMed ID: 26934439
[TBL] [Abstract][Full Text] [Related]
10. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of parapharyngeal extension in nasopharyngeal carcinoma treated with intensity modulated radiotherapy.
Tang LL; Sun Y; Mao YP; Chen Y; Li WF; Chen L; Liu LZ; Lin AH; Li L; Ma J
Radiother Oncol; 2014 Mar; 110(3):404-8. PubMed ID: 24183063
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Tang LL; Guo R; Zhou G; Sun Y; Liu LZ; Lin AH; Mai H; Shao J; Li L; Ma J
PLoS One; 2014; 9(10):e108375. PubMed ID: 25302611
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients.
Hu W; Zhu G; Guan X; Wang X; Hu C
Radiat Oncol; 2013 Oct; 8():230. PubMed ID: 24094078
[TBL] [Abstract][Full Text] [Related]
14. Failure patterns and prognostic factors for cervical node-negative nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
Wu Z; Wang L; Xie DH; Lv SW; Su Y; Shi YR
Asia Pac J Clin Oncol; 2021 Aug; 17(4):330-337. PubMed ID: 33079493
[TBL] [Abstract][Full Text] [Related]
15. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
[TBL] [Abstract][Full Text] [Related]
17. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
Ou X; Miao Y; Wang X; Ding J; He X; Hu C
Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
[TBL] [Abstract][Full Text] [Related]
18. Is replacement of the supraclavicular fossa with the lower level classification based on magnetic resonance imaging beneficial in nasopharyngeal carcinoma?
Yue D; Xu YF; Zhang F; Lin L; Mao YP; Li WF; Chen L; Sun Y; Liu LZ; Lin AH; Li L; Ma J
Radiother Oncol; 2014 Oct; 113(1):108-14. PubMed ID: 25245557
[TBL] [Abstract][Full Text] [Related]
19. Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study.
Li M; Huang XG; Yang ZN; Lu JY; Zhan YZ; Xie WJ; Zhou DJ; Wang L; Zhu DX; Lin ZX
Br J Radiol; 2016 Sep; 89(1065):20150621. PubMed ID: 27376590
[TBL] [Abstract][Full Text] [Related]
20. Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma.
Chen J; Ou D; He X; Hu C
Int J Clin Oncol; 2014 Dec; 19(6):998-1004. PubMed ID: 24337503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
